- Home
- ATOS vs ARBE Comparison
ATOS vs ARBE Comparison
Compare ATOS & ARBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- ARBE
- Stock Information
- Founded
- ATOS 2009
- ARBE 2015
- Country
- ATOS United States
- ARBE Israel
- Employees
- ATOS N/A
- ARBE N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- ARBE EDP Services
- Sector
- ATOS Health Care
- ARBE Technology
- Exchange
- ATOS Nasdaq
- ARBE Nasdaq
- Market Cap
- ATOS 174.8M
- ARBE 161.8M
- IPO Year
- ATOS 2012
- ARBE N/A
- Fundamental
- Price
- ATOS $1.47
- ARBE $1.92
- Analyst Decision
- ATOS Strong Buy
- ARBE Strong Buy
- Analyst Count
- ATOS 3
- ARBE 2
- Target Price
- ATOS $6.25
- ARBE $3.00
- AVG Volume (30 Days)
- ATOS 575.2K
- ARBE 50.7K
- Earning Date
- ATOS 11-12-2024
- ARBE 11-06-2024
- Dividend Yield
- ATOS N/A
- ARBE N/A
- EPS Growth
- ATOS N/A
- ARBE N/A
- EPS
- ATOS N/A
- ARBE N/A
- Revenue
- ATOS N/A
- ARBE $1,372,000.00
- Revenue This Year
- ATOS N/A
- ARBE $1.56
- Revenue Next Year
- ATOS N/A
- ARBE $2,120.36
- P/E Ratio
- ATOS N/A
- ARBE N/A
- Revenue Growth
- ATOS N/A
- ARBE N/A
- 52 Week Low
- ATOS $0.62
- ARBE $1.40
- 52 Week High
- ATOS $2.31
- ARBE $2.57
- Technical
- Relative Strength Index (RSI)
- ATOS 54.46
- ARBE 47.89
- Support Level
- ATOS $1.40
- ARBE $1.88
- Resistance Level
- ATOS $1.58
- ARBE $1.92
- Average True Range (ATR)
- ATOS 0.08
- ARBE 0.07
- MACD
- ATOS -0.00
- ARBE 0.00
- Stochastic Oscillator
- ATOS 52.17
- ARBE 45.16
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, USA, and others.